The risk of malignancies in patients receiving hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Keyvan HeydariA ShamshirianP Lotfi-ForoushaniA ArefA Hedayatizadeh-OmranM AhmadiG JanbabeiS KeyhanianE ZaboliS M GhasemzadehReza Alizadeh NavaeiPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
The meta-analysis findings showed that the risk of secondary cancers after HSCT was significantly increased in most types of cancers. Consequently, diagnostic tests for common cancers should be included in the screening program of these patients for the prevention and early detection of high-risk cancers.